Gene expression profiles associated with treatment response in oligodendrogliomas
- PMID: 16357140
- DOI: 10.1158/0008-5472.CAN-05-1886
Gene expression profiles associated with treatment response in oligodendrogliomas
Abstract
Oligodendrogliomas are a specific subtype of brain tumor of which the majority responds favorably to chemotherapy. In this study, we made use of expression profiling to identify chemosensitive oligodendroglial tumors. Correlation of expression profiles to loss of heterozygosity on 1p and 19q, common chromosomal aberrations associated with response to treatment, identified 376, 64, and 60 differentially expressed probe sets associated with loss of 1p, 19q or 1p, and 19q, respectively. Correlation of expression profiles to the tumors' response to treatment identified 16 differentially expressed probe sets. Because transcripts associated with chemotherapeutic response were identified independent of common chromosomal aberrations, expression profiling may be used as an alternative approach to the tumors' 1p status to identify chemosensitive oligodendroglial tumors. Finally, we correlated expression profiles to survival of the patient after diagnosis and identified 103 differentially expressed probe sets. The observation that many genes are differentially expressed between long and short survivors indicates that the genetic background of the tumor is an important factor in determining the prognosis of the patient. Furthermore, these transcripts can help identify patient subgroups that are associated with favorable prognosis. Our study is the first to correlate gene expression with chromosomal aberrations and clinical performance (response to treatment and survival) in oligodendrogliomas. The differentially expressed transcripts can help identify patient subgroups with good prognosis and those that will benefit from chemotherapeutic treatments.
Similar articles
-
Chromosomal anomalies in oligodendroglial tumors are correlated with clinical features.Cancer. 2003 Mar 1;97(5):1276-84. doi: 10.1002/cncr.11187. Cancer. 2003. PMID: 12599236
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.Cancer. 2003 May 1;97(9):2254-61. doi: 10.1002/cncr.11322. Cancer. 2003. PMID: 12712480
-
Oligodendrogliomas: clinical significance of 1p and 19q chromosomal deletions.Expert Rev Neurother. 2005 Nov;5(6 Suppl):S25-32. doi: 10.1586/14737175.5.6.S25. Expert Rev Neurother. 2005. PMID: 16274268 Review.
-
[The oligodendroglioma: the value of histologic and genetic diagnosis in predicting sensitivity to chemotherapy].Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1379-85. Ned Tijdschr Geneeskd. 2005. PMID: 15997690 Review. Dutch.
Cited by
-
hERG channel agonist NS1643 strongly inhibits invasive astrocytoma cell line SMA-560.PLoS One. 2024 Sep 6;19(9):e0309438. doi: 10.1371/journal.pone.0309438. eCollection 2024. PLoS One. 2024. PMID: 39240809 Free PMC article.
-
Sorcin in Cancer Development and Chemotherapeutic Drug Resistance.Cancers (Basel). 2024 Aug 9;16(16):2810. doi: 10.3390/cancers16162810. Cancers (Basel). 2024. PMID: 39199583 Free PMC article. Review.
-
Grading of oligodendroglioma in dogs based on magnetic resonance imaging.J Vet Intern Med. 2022 Nov;36(6):2104-2112. doi: 10.1111/jvim.16519. Epub 2022 Nov 10. J Vet Intern Med. 2022. PMID: 36366870 Free PMC article.
-
Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas.Sci Rep. 2022 Apr 19;12(1):6442. doi: 10.1038/s41598-022-10114-1. Sci Rep. 2022. PMID: 35440701 Free PMC article.
-
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2. Cochrane Database Syst Rev. 2022. PMID: 35233774 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources